Pay in 4 interest-free payments of $6.05 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Use of this information is at your own risk
These include both immune-stimulating and immune-suppressing peptides, depending on the therapeutic application
Potential Metabolic Rate Enhancement: Through activation of beta-3 adrenergic receptors and thermogenic effects, AOD-9604 may increase resting energy expenditure
Inger Sandlie and Jan Terje Andersen are inventors of the invention claimed in a patent family arising from WO2017158426 and WO2019057564 with the title Engineered immunoglobulins with altered FcRn binding
,aspect=ignore)
US$ 29.74
US$ 20.86
US$ 26.99
US$ 24.69
US$ 22.94
US$ 20.68
US$ 29.95
US$ 2324.50
Sold : Login>>
